Candice Halinski, MBA, MHCDS, MSN, NP-C, Director, Service Line Clinical, North Shore LIJ
Updated: 04/26/21
Updated: 04/26/21
Reader will identify conversion rate and characteristics of patients who reversed their decision to pursue conservative care.
Updated: 04/26/21
Implementation of Continuous Renal Replacement Therapy, monitoring the treatment and training and initiating Prismaflex/Prismax and ACDA anticoagulation.
Tags:
referral transplant
Updated: 04/26/21
Updated: 04/26/21
Discuss ways to increase referral to transpalnt center
Tags:
quality of life
support group
Updated: 04/26/21
Empower Home Dialysis patients through support group
Cindy A. Richards, BSN, RN, CNN, CCTC | Patricia Patterson, RN, CNN, Patient Safety and Risk Coordinator, St. Vincent's Hospital
Updated: 04/26/21
Updated: 04/26/21
Describe one benefit to their quality of life (QoL) to a child with a kidney or other solid organ transplant from attending a specialty camp.
Updated: 04/26/21
Updated: 04/26/21
TBD
Anita Settles-Seymour, MSN, RN | Melody N. Waller, PhD, RN | Jami S. Brown, DHEd., MSN, RN, CNN, Associate Professor, The University of Tennessee Health Science Center
Tags:
sexual dysfunction
Sexual health barriers
sexual health
progress of CKD
Sexual health strategies
Updated: 04/26/21
Updated: 04/26/21
Sexual dysfunction is a common, multifactorial problem affected by various physiological and psychological factors associated with the progression of chronic kidney disease (CKD). The interprofessional team needs to be knowledgeable of the causes and complications of CKD and identify barriers and strategies in addressing the sexual health of patients with CKD.
Molly L. Cahill, APRN, BC, NP-C, CNN, Nurse Practitioner, KC Kidney Consultants | Steven Fishbane, MD, Chief, Division of Nephrology, Northwell Health | Thomas Wooldridge, MD | Warren Wen, PhD | Catherine Munera, PhD | Frederique Menzaghi, PhD
Updated: 04/26/21
Updated: 04/26/21
The participant will be able to describe efficacy of difelikefalin for improving itch-related quality of life in patients with moderate-to-severe chronic kidney disease–associated pruritus
Updated: 04/26/21
Updated: 04/26/21
Debbie Barrera, BSN | Georges Deschenes, MD | Pierre Cochat, MD | Daniella Magen, MD | William VantHoff, MD | Mini Michael, MD | David Sas, MD | Gesa Schalk, MD | Hadas Sasha-Lavsky, MD | Wesley Hayes, MD | Kyoungwha Bae, PhD | Ali Seddighzadeh, MD | Pushkal Garg, MD | Akshay Vaishnaw, MD | Tracy McGregor, MD | Kenji Fujita, MD | Yaacov Frishberg, MD
Updated: 04/26/21
Updated: 04/26/21
Participants will be able to evaluate the impact of lumasiran, a RNAi therapuetic in young children with primary hyperoxaluria type 1 (PH1)- a rare genetic kidney disorder
